|
|
Gene Symbol |
NFE2L2 |
|
Aliases |
HEBP1, IMDDHH, NRF2, Nrf-2 |
|
Entrez Gene ID |
|
|
Gene Name |
Nuclear factor, erythroid 2 like 2 |
|
Chromosomal Location |
2q31.2 |
|
HGNC ID |
|
|
Summary |
This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015]
|
|
e!Ensembl
Gene |
|
|
Transcript |
ENST00000458603, ENST00000397063, ENST00000397062, ENST00000446151, ENST00000464747, ENST00000449627, ENST00000448782, ENST00000430047, ENST00000586532, ENST00000421929, ENST00000423513, ENST00000588123 |
|
Protein |
ENSP00000416308, ENSP00000380253, ENSP00000380252, ENSP00000411575, ENSP00000467401, ENSP00000391590, ENSP00000400073, ENSP00000391291, ENSP00000464920, ENSP00000412191, ENSP00000410015, ENSP00000468089
|
|
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0006366 |
Biological process |
Transcription by RNA polymerase II |
TAS |
7937919 |
GO:0010499 |
Biological process |
Proteasomal ubiquitin-independent protein catabolic process |
IDA |
19424503 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IGI |
22492997 |
GO:0016567 |
Biological process |
Protein ubiquitination |
IDA |
15983046 |
GO:0034599 |
Biological process |
Cellular response to oxidative stress |
IBA |
21873635 |
GO:0034599 |
Biological process |
Cellular response to oxidative stress |
NAS |
22013210 |
GO:0034599 |
Biological process |
Cellular response to oxidative stress |
TAS |
22934019 |
GO:0036003 |
Biological process |
Positive regulation of transcription from RNA polymerase II promoter in response to stress |
IMP |
23043106 |
GO:0036499 |
Biological process |
PERK-mediated unfolded protein response |
TAS |
22934019 |
GO:0043161 |
Biological process |
Proteasome-mediated ubiquitin-dependent protein catabolic process |
IDA |
15983046 |
GO:0045454 |
Biological process |
Cell redox homeostasis |
IMP |
29018201 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IBA |
21873635 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IC |
22492997 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
17015834 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
18202225, 25190803 |
GO:0061419 |
Biological process |
Positive regulation of transcription from RNA polymerase II promoter in response to hypoxia |
IMP |
24844779 |
GO:0070301 |
Biological process |
Cellular response to hydrogen peroxide |
IMP |
23043106 |
GO:0071356 |
Biological process |
Cellular response to tumor necrosis factor |
IMP |
18202225 |
GO:0071498 |
Biological process |
Cellular response to fluid shear stress |
IDA |
25190803 |
GO:0071499 |
Biological process |
Cellular response to laminar fluid shear stress |
IMP |
23043106 |
GO:1902176 |
Biological process |
Negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
IMP |
23043106 |
GO:1903071 |
Biological process |
Positive regulation of ER-associated ubiquitin-dependent protein catabolic process |
TAS |
23800989 |
GO:1903206 |
Biological process |
Negative regulation of hydrogen peroxide-induced cell death |
IGI |
22492997 |
GO:2000352 |
Biological process |
Negative regulation of endothelial cell apoptotic process |
IMP |
23043106 |
GO:0005634 |
Cellular component |
Nucleus |
IBA |
21873635 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
18202225, 18554677, 22492997, 23043106 |
GO:0005737 |
Cellular component |
Cytoplasm |
IBA |
21873635 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
22492997 |
GO:0005829 |
Cellular component |
Cytosol |
IDA |
23043106 |
GO:0000976 |
Molecular function |
Transcription regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000976 |
Molecular function |
Transcription regulatory region sequence-specific DNA binding |
TAS |
24252804 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0001102 |
Molecular function |
RNA polymerase II activating transcription factor binding |
IPI |
23043106 |
GO:0003677 |
Molecular function |
DNA binding |
IDA |
18554677 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IBA |
21873635 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
17015834 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
16888629, 17015834, 18048326, 18692475, 18757741, 19706542, 21597468, 21988832, 25416956, 26700459, 28777872 |
GO:0019904 |
Molecular function |
Protein domain specific binding |
IPI |
11256947 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
TAS |
17015834 |
|
Protein Information |
|
Protein Name |
Nuclear factor erythroid 2-related factor 2, nuclear factor erythroid-derived 2-like 2 |
|
Function |
Transcription factor that plays a key role in the response to oxidative stress: binds to antioxidant response (ARE) elements present in the promoter region of many cytoprotective genes, such as phase 2 detoxifying enzymes, and promotes their expression, thereby neutralizing reactive electrophiles (PubMed:11035812, PubMed:19489739, PubMed:29018201, PubMed:31398338). In normal conditions, ubiquitinated and degraded in the cytoplasm by the BCR(KEAP1) complex (PubMed:11035812, PubMed:15601839, PubMed:29018201). In response to oxidative stress, electrophile metabolites inhibit activity of the BCR(KEAP1) complex, promoting nuclear accumulation of NFE2L2/NRF2, heterodimerization with one of the small Maf proteins and binding to ARE elements of cytoprotective target genes (PubMed:19489739, PubMed:29590092). The NFE2L2/NRF2 pathway is also activated in response to selective autophagy: autophagy promotes interaction between KEAP1 and SQSTM1/p62 and subsequent inactivation of the BCR(KEAP1) complex, leading to NFE2L2/NRF2 nuclear accumulation and expression of cytoprotective genes (PubMed:20452972). May also be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region (PubMed:7937919). |
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF03131 |
bZIP_Maf |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000368100 |
Q92878 |
Q92878 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Heart Failure |
|
Myocardial Failure |
|
Digestive System Diseases |
Non-alcoholic Fatty Liver Disease |
|
Liver Fibrosis |
|
Liver Cirrhosis |
|
Cholestasis |
|
Liver Diseases |
|
Fatty Liver |
|
Cholera Infantum |
|
Hepatitis |
|
Gastrointestinal Diseases |
|
Endocrine System Diseases |
Ovarian Failure |
|
Glomerulosclerosis |
|
Gonadotropin-Resistant Ovary Syndrome |
|
PCOS |
|
Immune System Diseases |
Dermatitis |
|
Neoplasms |
Liver Cancer |
|
Endometrial Cancer |
|
Lung Cancer |
|
Skin Cancer |
|
Prostate cancer |
|
Carcinoma |
|
Pancreatic Neoplasm |
|
Esophagus Neoplasm |
|
Head Neoplasms |
|
Renal Cancer |
|
Bladder Cancer |
|
Nutritional and Metabolic Diseases |
Hyperglycemia |
|
Immunodeficiency, Developmental Delay, And Hypohomocysteinemia |
|
Psychiatric/Brain disorders |
Obstructive Sleep Apnea |
|
Renal Disorder |
Diabetic Nephropathy |
|
Kidney Insufficiency |
|
Kidney Failure |
|
Reproductive disorders |
Ovarian Failure |
|
Preeclampsia |
|
Respiratory Tract Diseases |
Pulmonary Fibrosis |
|
Skin and Connective Tissue Diseases |
Keratosis |
|
|
References |
|
|
Lu Jiayin, Wang Zixu, Cao Jing, Chen Yaoxing, Dong Yulan |
Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China. yxchen@cau.edu.cn.| Laboratory of Neurobiology, College of Animal Medicine, China Agricultural University, Haidian, Beijing, 100193, People's Republic of China. ylbcdong@cau.edu.cn. |
Reprod Biol Endocrinol. 2018 Aug 20;16(1):80. doi: 10.1186/s12958-018-0391-5. |
Abstract
In recent years, the study of oxidative stress (OS) has become increasingly popular. In particular, the role of OS on female fertility is very important and has been focused on closely. The occurrence of OS is due to the excessive production of reactive oxygen species (ROS). ROS are a double-edged sword; they not only play an important role as secondary messengers in many intracellular signaling cascades, but they also exert indispensable effects on pathological processes involving the female genital tract. ROS and antioxidants join in the regulation of reproductive processes in both animals and humans. Imbalances between pro-oxidants and antioxidants could lead to a number of female reproductive diseases. This review focuses on the mechanism of OS and a series of female reproductive processes, explaining the role of OS in female reproduction and female reproductive diseases caused by OS, including polycystic ovary syndrome (PCOS), endometriosis, preeclampsia and so on. Many signaling pathways involved in female reproduction, including the Keap1-Nrf2, NF-kappaB, FOXO and MAPK pathways, which are affected by OS, are described, providing new ideas for the mechanism of reproductive diseases. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|